EU watchdog urges vaccine developers not to focus only on Omicron
Vaccine makers working on a redesign of their established shots to address Omicron, which is crowding out the Delta variant in many regions of the world, include BioNTech-Pfizer , Moderna and the alliance between AstraZeneca and Oxford University. BioNTech Chief Executive Ugur Sahin last week questioned the need to develop products tailored to more than just Omicron because immunity against Omicron has been shown to be likely to confer protection against preceding virus variants.
The European Union drugs regulator said pharmaceuticals companies should work on more than one upgraded COVID-19 shot, not only tailored to the fast-emerging Omicron variant but also versions that address a combination of variants.
"What we are hearing from other regulatory agencies also is that it is important not to exclude any options," the European Medicines Agency's head of vaccines strategy, Marco Cavaleri, told a media briefing on Tuesday. Vaccine makers working on a redesign of their established shots to address Omicron, which is crowding out the Delta variant in many regions of the world, include BioNTech-Pfizer , Moderna and the alliance between AstraZeneca and Oxford University.
BioNTech Chief Executive Ugur Sahin last week questioned the need to develop products tailored to more than just Omicron because immunity against Omicron has been shown to be likely to confer protection against preceding virus variants. "Omicron infection and an Omicron vaccine will most likely, with a high probability, also boost immune responses against all existing variants," Sahin had said in an analyst call as part of J.P.Morgan's virtual healthcare conference.
"What is the value if we now combine a potential Omicron vaccine with another variant as the Omicron vaccine alone would most likely do the job?" he added.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
ALSO READ
Bhutan's Health Minister lauds India's Maitri initiative, says country was "fortunate" to receive 150,000 doses of vaccines during COVID
Brazil's Bolsonaro indicted for suspected fraud on vaccine records
Conference On Anti-Microbial Resistance, Novel Drug Discovery And Vaccine Development Organized By SRM University Haryana
China's Stemirna halts mRNA cancer vaccine trial, researchers say
China's Stemirna halts mRNA cancer vaccine trial, researchers say